SCLX MEXC RealStocks
Own real SCLX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 04:55:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Scilex Holding Company (SCLX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.43, with a market capitalization of $10.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.40 to $27.00. This page covers its latest market performance, valuation, price trends and company information.
$10.06M | |
$1.55 | |
$1.64 | |
$1.42 | |
$1.56 | |
57.93K | |
41.69K | |
-- | |
$27.00 | |
$1.40 | |
-- | |
-- |
Scilex Holding Company (SCLX) last closed at $1.43 as of 2026-11-14 00:40:00, down 7.74% ($0.12) from the previous close of $1.56.
During the latest regular trading session, SCLX traded between $1.42 and $1.64, with a volume of 57.93K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Scilex Holding Company (SCLX) moved from $1.70 to $1.43, representing a decline of 15.88% ($0.27).
The stock traded between $1.40 and $1.83 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 40.24 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.1%
SCLX is currently trading at $1.43, placing it 0.1% of the way from its 52-week low of $1.40 to its 52-week high of $27.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 34 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Scilex Holding Company (SCLX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SCLX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SCLX shares and USD.
SCLX Shares to USD
1.00 SCLX shares = 1.43 USD
Calculations are estimates based on the latest available price and are for reference only.